NCT05985590View on ClinicalTrials.gov

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 18, 2023

Primary Completion Date

December 11, 2023

Study Completion Date

December 11, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986278

Specified dose on specified days

DRUG

Drospirenone/Ethinyl Estradiol

Specified dose on specified days

Trial Locations (1)

G1P 0A2

Local Institution - 0002, Québec

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05985590 - A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants | Biotech Hunter | Biotech Hunter